Literature DB >> 1409355

Improved delivery through biological membranes. XLV. Synthesis, physical-chemical evaluation, and brain uptake studies of 2-chloroethyl nitrosourea delivery systems.

K Raghavan1, T Loftsson, M E Brewster, N Bodor.   

Abstract

The dihydropyridine in equilibrium with pyridinium redox chemical delivery system (CDS) was supplied to two 2-chloroethylnitrosoureas, i.e., HECNU and CCNUOH, and the physicochemical properties of the delivery systems were studied to assess their potential as improved delivery forms to the CNS. Detailed physicochemical evaluation and brain uptake studies were performed on one of the delivery systems (CCNUOH-CDS) derived from trans-4-hydroxy-CCNU, an active metabolite of CCNU. Two aqueous-based formulations derived from hydroxypropyl-beta-cyclodextrin (HP beta CD) and Tween 80:ethanol:water system were developed for CCNUOH-CDS to overcome the poor aqueous solubility conferred upon it by its high lipophilicity. The formulations enabled a 200- to 400-fold improvement in the water solubility of CCNUOH-CDS. Dose- and vehicle-dependent comparative tissue distribution studies in rats indicated improved brain-to-organ ratios of the delivery system at lower doses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409355     DOI: 10.1023/a:1015843219733

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Clinical studies with nitrosoureas in various solid tumors.

Authors:  M Slavik
Journal:  Cancer Treat Rep       Date:  1976-06

2.  Nitrosourea chemotherapy for primary malignant gliomas.

Authors:  V A Levin; C B Wilson
Journal:  Cancer Treat Rep       Date:  1976-06

3.  Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962.

Authors:  V T De Vita; P P Carbone; A H Owens; G L Gold; M J Krant; J Edmonson
Journal:  Cancer Res       Date:  1965-12       Impact factor: 12.701

Review 4.  Problems of delivery of drugs to the brain.

Authors:  N Bodor; M E Brewster
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

5.  Targeting of drugs to the brain.

Authors:  N Bodor
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

6.  Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives.

Authors:  J Pitha; T Irie; P B Sklar; J S Nye
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

7.  2-chloroethanol formation as evidence for a 2-chloroethyl alkylating intermediate during chemical degradation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.

Authors:  D J Reed; H E May; R B Boose; K M Gregory; M A Beilstein
Journal:  Cancer Res       Date:  1975-03       Impact factor: 12.701

8.  Activated N-nitrosocarbamates for regioselective synthesis of N-nitrosoureas.

Authors:  J Martinez; J Oiry; J L Imbach; F Winternitz
Journal:  J Med Chem       Date:  1982-02       Impact factor: 7.446

9.  Nitrosoureas in the management of disseminated malignant melanoma.

Authors:  D L Ahmann
Journal:  Cancer Treat Rep       Date:  1976-06

10.  Improved delivery through biological membranes. XXX. Synthesis and biological aspects of a 1,4-dihydropyridine based chemical delivery system for brain-sustained delivery of hydroxy CCNU.

Authors:  K S Raghavan; E Shek; N Bodor
Journal:  Anticancer Drug Des       Date:  1987-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.